AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Borregaard

Quarterly Report May 3, 2023

3562_rns_2023-05-03_62f64a95-d8a9-4ce9-bee6-2ae2245f3245.pdf

Quarterly Report

Open in Viewer

Opens in native device viewer

Income Statement Borregaard Group Q1 2023
1.1-31.3 1.1-31.12
Amounts in NOK million 2023 2022 2022
Operating revenues 1 850 1 615 6 881
Operating expenses -1 415 -1 215 -5 238
EBITDA 435 400 1 643
Depreciation property, plant and equipment -114 -108 -444
Amortisation intangible assets -1 -1 -5
Other income and expenses 0 0 -8
Operating profit 320 291 1 186
Financial items, net -28 -14 -68
Profit before taxes 292 277 1 118
Income tax expence -71 -68 -267
Profit for the period 221 209 851
Profit attributable to non-controlling interests -10 -8 -41
Profit attributable to owners of the parent 231 217 892
Earnings per share (NOK) 2,32 2,18 8,95
EBITDA margin 23,5 % 24,8 % 23,9 %
Interim condensed statement of financial position Borregaard Group
31.3. 31.12.
Amounts in NOK million 2023 2022
Assets:
Intangible assets 82 82
Property, plant and equipment 4 436 4 371
Right-of-use assets 350 345
Other assets 217 254
Investments in joint venture/associate company 136 142
Non-current assets 5 221 5 194
Inventories 1 373 1 299
Receivables 1 560 1 387
Cash and cash deposits 217 234
Current assets 3 150 2 920
Total assets 8 371 8 114
Equity and debt:
Group equity 4 260 4 394
Non-controlling interests 44 51
Equity 4 304 4 445
Provisions and other liabilities 435 295
Interest-bearing liabilities 1 490 1 370
Non-current liabilities 1 925 1 665
Interest-bearing liabilities 657 702
Other current liabilities 1 485 1 302
Current liabilities 2 142 2 004
Equity and liabilities 8 371 8 114
Equity ratio (%): 51,4 % 54,8 %
Interim condensed cash flow statement Borregaard Group Q1 2023
1.1-31.3 1.1-31.12
Amounts in NOK million 2023 2022 2022
Profit before taxes 292 277 1 118
Amortisation, depreciation and impairment charges 115 109 449
Change in net working capital, etc -193 -381 -658
Dividend/share of profit from JV & associate company 6 0 34
Taxes paid -109 -77 -208
Cash flow from operating activities 111 -72 735
Investments property, plant and equipment and intangible assets * -107 -87 -464
Investment in associate company 0 0 0
Other capital transactions 2 2 9
Cash flow from Investing activities -105 -85 -455
Dividends 0 0 -499
Proceeds from exercise of options/shares to employees 41 27 41
Buy-back of shares -41 -4 -68
Gain/(loss) on hedges for net investments in subsidiaries -58 31 -79
Net paid to/from shareholders -58 54 -605
Proceeds from interest-bearing liabilities 0 100 837
Repayment of interest-bearing liabilities -14 -14 -512
Change in interest-bearing receivables/other liabilities 41 -2 78
Change in net interest-bearing liablities 27 84 403
Cash flow from financing activities -31 138 -202
Change in cash and cash equivalents -25 -19 78
Cash and cash equivalents at beginning of period 111 5 5
Change in cash and cash equivalents -25 -19 78
Currency effects cash and cash equivalents 19 -2 28
Cash and cash equivalents at the end of the period 105 -16 111
* Investment by category:
Replacement investments 87 71 359
Expansion investments including investment in associate company 20 16 105
Total investments including investment in associate company 107 87 464
Quarterly segment information Borregaard Group
Operating revenues
1.1-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3
Amounts in NOK million 2019 2020 2021 2021 2021 2021 2021 2022 2022 2022 2022 2022 2023
Borregaard 5 063 5 328 1 419 1 511 1 429 1 446 5 805 1 615 1 744 1 752 1 770 6 881 1 850
BioSolutions 2 982 3 082 812 885 838 934 3 469 948 1 098 1 007 997 4 050 995
BioMaterials 1 712 1 732 523 482 468 405 1 878 532 540 558 620 2 250 684
Fine Chemicals 406 543 90 155 132 114 491 143 119 200 170 632 180
EBITDA
1.1-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3
Amounts in NOK million 2019 2020 2021 2021 2021 2021 2021 2022 2022 2022 2022 2022 2023
Borregaard 1 007 1 132 302 416 391 263 1 372 400 445 434 364 1 643 435
BioSolutions 647 632 205 272 251 214 942 261 305 261 159 986 224
BioMaterials 234 318 64 102 91 27 284 97 91 101 138 427 127
Fine Chemicals 126 182 33 42 49 22 146 42 49 72 67 230 84

Eliminations - 37 - 29 - 6 - 11 - 9 - 7 - 33 -8 -13 -13 -17 -51 -9

Depreciations and write downs
1.1-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3
Amounts in NOK million 2019 2020 2021 2021 2021 2021 2021 2022 2022 2022 2022 2022 2023
Borregaard - 418 - 443 - 106 - 101 - 103 - 106 - 416 -108 -110 -112 -114 -444 -114
BioSolutions - 183 - 206 - 48 - 45 - 47 - 49 - 189 -50 -53 -54 -55 -212 -56
BioMaterials - 203 - 203 - 50 - 47 - 47 - 49 - 193 -49 -48 -49 -49 -195 -49
Fine Chemicals - 32 - 34 - 8 - 9 - 9 - 8 - 34 -9 -9 -9 -10 -37 -9
Amortisation
1.1-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3
Amounts in NOK million 2019 2020 2021 2021 2021 2021 2021 2022 2022 2022 2022 2022 2023
Borregaard - 4 - 5 - 1 - 1 - 1 - 1 - 4 -1 -1 -1 -2 -5 -1
BioSolutions - 4 - 5 - 1 - 1 - 1 - 1 - 4 -1 -1 -1 -2 -5 -1
BioMaterials 0 0 0 0 0 0 0 0 0 0 0 0 0
Fine Chemicals 0 0 0 0 0 0 0 0 0 0 0 0 0
Other income and expenses
1.1-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3
Amounts in NOK million 2019 2020 2021 2021 2021 2021 2021 2022 2022 2022 2022 2022 2023
Borregaard -27 -116 0 0 0 0 0 0 12 0 -20 -8 0
BioSolutions -16 -97 0 0 0 0 0 0 12 0 -6 6 0
BioMaterials -11 -18 0 0 0 0 0 0 0 0 -12 -12 0
Fine Chemicals 0 - 1 0 0 0 0 0 0 0 0 -2 -2 0
Operating profit (EBIT)
1.1-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3
Amounts in NOK million 2019 2020 2021 2021 2021 2021 2021 2022 2022 2022 2022 2022 2023
Borregaard 558 568 195 314 287 156 952 291 346 321 228 1 186 320
BioSolutions 444 324 156 226 203 164 749 210 263 206 96 775 167
BioMaterials 20 97 14 55 44 - 22 91 48 43 52 77 220 78
Fine Chemicals 94 147 25 33 40 14 112 33 40 63 55 191 75
Hedging effects & currency exposure
1.1-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3
Amounts in NOK million 2019 2020 2021 2021 2021 2021 2021 2022 2022 2022 2022 2022 2023
Borregaard - EBITDA hedging gains & losses -76 -241 -15 -4 -16 6 -29 10 -3 -23 -34 -50 -48
BioSolutions -33 -103 -5 -1 -6 1 -11 3 -5 -19 -23 -44 -25
BioMaterials -37 -116 -8 -3 -8 4 -15 5 1 -4 -9 -7 -19
Fine Chemicals -6 -22 -2 0 -2 1 -3 2 1 0 -2 1 -4
Borregaard - USD EBITDA currency exposure (approx) 203 177 198 197
Borregaard - EUR EBITDA currency exposure (approx) 98 112 139 147
Sales revenues
1.1-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3
Amounts in NOK million 2019 2020 2021 2021 2021 2021 2021 2022 2022 2022 2022 2022 2023
Borregaard 4 951 5 227 1 394 1 491 1 406 1 424 5 715 1 591 1 720 1 723 1 742 6 776 1 825
BioSolutions 2 873 2 995 793 865 819 915 3 392 929 1 072 979 966 3 946 973
BioMaterials 1 679 1 695 513 472 457 398 1 840 521 530 546 608 2 205 674
Fine Chemicals 400 538 88 154 131 112 485 141 118 198 168 625 178
Eliminations - 1 - 1 0 0 - 1 - 1 - 2 0 0 0 0 0 0
BioSolutions
1.1-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3
2019 2020 2021 2021 2021 2021 2021 2022 2022 2022 2022 2022 2023
Average gross sales price NOK per mtds 6 166 6 951 7 838 7 709 7 761 9 244 8 106 9 780 10 150 10 479 11 104 10 369 12 402
Volume (`000 mtds) 470 416 90 100 92 84 366 81 90 84 79 334 74
Specialities volume (`000 mtds) 86 88 89 84
Contruction volume (`000 mtds) 209 178 131 117
Industrial volume (`000 mtds) 175 150 146 133
BioMaterials
1.1-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3 1.4-30.6 1.7-30.9 1.10-31.12 1.1-31.12 1.1-31.3
2019 2020 2021 2021 2021 2021 2021 2022 2022 2022 2022 2022 2023
Average gross sales price NOK per mt 10 665 11 678 10 641 10 754 10 972 10 911 10 807 12 595 13 656 14 880 16 179 14 283 16 449
Volume (`000 mt) 153,1 148,4 47,5 42,4 40,2 34,3 164,4 39,4 36,6 34,7 36,3 147,0 40,0

Talk to a Data Expert

Have a question? We'll get back to you promptly.